Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.97 -0.05 (-4.90%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Total Non-Current Liabilities (2022 - 2023)

Updated

Cadrenal Therapeutics (CVKD) posted Total Non-Current Liabilities of -$3.55 million for Q4 2023, compared with $1.95 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Total Non-Current Liabilities (2022 - 2023) Analysis & Trends

  • In prior years, Cadrenal Therapeutics' Total Non-Current Liabilities was $1.95 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 102.65 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 106.45 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 33.91 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 97.04 Bn
10 Cadrenal Therapeutics 2.91 Mn -9.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -3.55 Mn
Dec 31, 2022 1.95 Mn
API Access

Cadrenal Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CVKD&period=max&api_key=YOUR_API_KEY